Dr. Reema Hameed Syed, MD

Dr. Syed practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Syed's NPI, 1588872758, was assigned on May 19, 2007. Dr. Syed holds Missouri license 2006009294.

Dr. Syed's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Syed also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Syed's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Syed is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Syed to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Syed practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Syed's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Syed is licensed in Missouri.

CMS data shows 2,507 Medicare services from Dr. Syed across 9 procedure codes in 2024, for 281 Medicare patients. Medicare paid $68,595 for them.

CMS counts 281 Medicare patients who saw Dr. Syed in 2024. The largest group is 65 to 74, with 130 patients. 72% of them have high blood pressure, and 71% have arthritis. 11% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Syed's median patient age at 62, with 77% women.

In 2024, Dr. Syed wrote 1,393 Medicare Part D claims for 189 patients. 79% of them were for generic drugs. CMS names the drug for 1,279 of them, across 25 drugs with 11 or more claims each, at $1,391,062 in total drug cost. In 2023, CMS named 1,154 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Syed for performance year 2024, reported as part of a group. Dr. Syed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Syed as offering telehealth.

Dmand AI links 8 papers to Dr. Syed, published from 2011 to 2016. The most frequent topics are Eye Foreign Bodies, Eye Injuries, Penetrating and Vitrectomy. Dr. Syed has published most often in Retina. Dr. Syed's most frequent co-authors are Shlomit Schaal, MD, PhD, Hermine Isabel Brunner, MD and Joyce J. Hsu, MD.

Dmand AI links Dr. Syed to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Negative rheumatoid factor polyarthritis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Syed that name 1 trial.

CMS Open Payments shows 45 general payments to Dr. Syed from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Swedish Orphan Biovitrum AB paid the most, $1,161. It also lists 1 research payment totaling $435 in 2019, naming 1 clinical trial.